PT1558620E - Complexos anticancerígenos de ruténio - Google Patents

Complexos anticancerígenos de ruténio Download PDF

Info

Publication number
PT1558620E
PT1558620E PT03762788T PT03762788T PT1558620E PT 1558620 E PT1558620 E PT 1558620E PT 03762788 T PT03762788 T PT 03762788T PT 03762788 T PT03762788 T PT 03762788T PT 1558620 E PT1558620 E PT 1558620E
Authority
PT
Portugal
Prior art keywords
ruthenium
anticancer complexes
ruthenium anticancer
complexes
formula
Prior art date
Application number
PT03762788T
Other languages
English (en)
Portuguese (pt)
Inventor
Peter John Sadler
Rafael Fernandez Lainez
Abraba Habtemariam
Michael Melchart
Duncan Ian Jodrell
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Publication of PT1558620E publication Critical patent/PT1558620E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00Metallocenes
    • C07F17/02Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT03762788T 2002-07-05 2003-07-04 Complexos anticancerígenos de ruténio PT1558620E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0215526.5A GB0215526D0 (en) 2002-07-05 2002-07-05 Anticancer compounds

Publications (1)

Publication Number Publication Date
PT1558620E true PT1558620E (pt) 2008-12-03

Family

ID=9939861

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03762788T PT1558620E (pt) 2002-07-05 2003-07-04 Complexos anticancerígenos de ruténio

Country Status (20)

Country Link
US (1) US20060058270A1 (enExample)
EP (1) EP1558620B1 (enExample)
JP (1) JP2005536487A (enExample)
KR (1) KR20050053589A (enExample)
CN (1) CN100362005C (enExample)
AT (1) ATE407937T1 (enExample)
AU (1) AU2003251159B2 (enExample)
BR (1) BR0312470A (enExample)
CA (1) CA2491640A1 (enExample)
DE (1) DE60323529D1 (enExample)
DK (1) DK1558620T3 (enExample)
ES (1) ES2314245T3 (enExample)
GB (1) GB0215526D0 (enExample)
MX (1) MXPA05000314A (enExample)
NO (1) NO20050640L (enExample)
NZ (1) NZ538005A (enExample)
PL (1) PL373049A1 (enExample)
PT (1) PT1558620E (enExample)
WO (1) WO2004005304A1 (enExample)
ZA (1) ZA200500908B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE303393T1 (de) * 1999-10-27 2005-09-15 Univ Court The University Of E Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
US7241913B2 (en) 2003-04-30 2007-07-10 The University Court Of The University Of Edinburgh Ruthenium compounds
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
EP2016085B9 (en) * 2006-05-09 2015-12-30 Ecole Polytechnique Fédérale de Lausanne (EPFL) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
DE102009053392A1 (de) * 2009-11-14 2011-06-22 Umicore AG & Co. KG, 63457 Verfahren zur Herstellung von Ru(0) Olefin-Komplexen
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
CN103360428A (zh) * 2012-04-09 2013-10-23 中国科学院化学研究所 抑制蛋白酪氨酸磷酸酶1b活性的含钌配合物及其制备方法和蛋白酪氨酸磷酸酶1b抑制剂
CN102964385B (zh) * 2012-11-30 2015-02-18 广西师范学院 一种有机金属钌化合物及其制备方法和用途
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same
CZ310511B6 (cs) * 2023-09-18 2025-09-10 Univerzita Palackého v Olomouci Koordinační sloučeniny osmia pro použití pro léčbu plicních nádorových onemocnění

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
DE69634639T2 (de) * 1995-12-06 2006-03-02 Japan Science And Technology Agency, Kawaguchi Verfahren zur herstellung optische aktive verbindungen
ATE303393T1 (de) * 1999-10-27 2005-09-15 Univ Court The University Of E Halbsandwich ruthenium(ii)-verbindungen mit einem stickstoff-haltigen liganden zur krebstherapie
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds

Also Published As

Publication number Publication date
WO2004005304A1 (en) 2004-01-15
EP1558620A1 (en) 2005-08-03
BR0312470A (pt) 2005-04-26
ATE407937T1 (de) 2008-09-15
US20060058270A1 (en) 2006-03-16
CN1665826A (zh) 2005-09-07
DE60323529D1 (de) 2008-10-23
GB0215526D0 (en) 2002-08-14
NO20050640L (no) 2005-03-22
ES2314245T3 (es) 2009-03-16
KR20050053589A (ko) 2005-06-08
AU2003251159B2 (en) 2008-11-06
EP1558620B1 (en) 2008-09-10
NZ538005A (en) 2007-08-31
CA2491640A1 (en) 2004-01-15
ZA200500908B (en) 2006-03-29
JP2005536487A (ja) 2005-12-02
PL373049A1 (en) 2005-08-08
DK1558620T3 (da) 2009-01-05
CN100362005C (zh) 2008-01-16
AU2003251159A1 (en) 2004-01-23
MXPA05000314A (es) 2005-09-20

Similar Documents

Publication Publication Date Title
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
PL367682A1 (en) Dolastatin 10 derivatives
IL164509A0 (en) Furyl compounds
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
ZA200500908B (en) Ruthenium anticancer complexes
AU2003212634A1 (en) Compounds useful in the treatment of cancer
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
IL159993A0 (en) Platinum complexes and their use in cancer treatment
AU2003300385A8 (en) Anticancer compounds
MY130957A (en) Triazine derivatives and their application as antitelomerase agents
WO2000063219A8 (en) Platinum complexes for the treatment of cancer
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
MXPA06000372A (es) Compuestos de silicio y su uso.
PT1618116E (pt) Complexos de ruténio(ii) para o tratamento de tumores
WO2001028593A3 (en) Conjugates useful in the treatment of prostate cancer
GB0012795D0 (en) Organic compounds
WO2005016958A3 (en) Compounds for treating tumors
GB0015446D0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
ATE336244T1 (de) Metallorganisches antitumormittel
WO2003014128A3 (de) Tumorhemmende cerverbindungen
MX2008001548A (es) Compuestos antitumorales.
IL159469A0 (en) Xenogenic oligo-or/and polyribonucleotides as agents for the treatment of malignant tumours
DE60220504D1 (en) Tryptasehemmer